These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19377492)

  • 41. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
    Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
    Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything.
    Feldman AM
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):549-51. PubMed ID: 25714600
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.
    Li Y; Jing L; Li Y; Jiang J; Wang Z; Wei J; Li X; Wang L; Xia H; Li T; Liu S; Xing B; Yang Z; Lu Q; Jiang R; Xie P; Shou X; Wang X; Jia Y
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1183-91. PubMed ID: 24757084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ivabradine for the treatment of stable angina pectoris in octogenarians.
    Koester R; Kaehler J; Meinertz T
    Clin Res Cardiol; 2011 Feb; 100(2):121-8. PubMed ID: 20821016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
    de Vries RJ; van den Heuvel AF; Lok DJ; Claessens RJ; Bernink PJ; Pasteuning WH; Kingma JH; Dunselman PH
    Int J Cardiol; 1996 Dec; 57(2):143-50. PubMed ID: 9013266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angina pectoris: improving symptoms and prognosis. With ivabradine less angina pectoris and reduced need for nitrates].
    MMW Fortschr Med; 2011 Jun; 153(24-25):56-7. PubMed ID: 21717715
    [No Abstract]   [Full Text] [Related]  

  • 51. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
    Nedoshivin A; Petrova PTS; Karpov Y
    Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Heart rate reduction as a therapeutic strategy: novel options].
    Hoppe UC
    Internist (Berl); 2006 Dec; 47(12):1289-93. PubMed ID: 17077980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ivabradine--a medical alternative for patients with chronic stable angina pectoris].
    Haghfelt TH
    Ugeskr Laeger; 2006 Nov; 168(46):3991-3. PubMed ID: 17125651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
    Borer JS; Swedberg K; Komajda M; Ford I; Tavazzi L; Böhm M; Depre C; Wu Y; Maya J; Dominjon F
    Cardiology; 2017; 136(2):138-144. PubMed ID: 27614723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.